Evidence map›Paper›PMID 27741243›Full record

ArticlePLoS genetics2016

Amplification of TLO Mediator Subunit Genes Facilitate Filamentous Growth in Candida Spp.

Zhongle Liu, Gary P Moran, Derek J Sullivan, Donna M MacCallum, Lawrence C Myers

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Paralogs of thebioRxiv : the preprint server for biology · 2026
    Article
  2. Fluconazole resistance andMicrobiology (Reading, England) · 2025
    Article
  3. Med3-mediated NADPH generation to helpApplied and environmental microbiology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Mediator Subunit Med15 Regulates Cell Morphology and Mating inJournal of fungi (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Lineage-specific selection and the evolution of virulence in theProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Zhongle LiuDepartment of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America.
Gary P MoranMicrobiology Research Unit, Division of Oral Biosciences, Dublin Dental University Hospital, University of Dublin, Dublin, Ireland.
Derek J SullivanMicrobiology Research Unit, Division of Oral Biosciences, Dublin Dental University Hospital, University of Dublin, Dublin, Ireland.ORCID http://orcid.org/0000-0003-0195-9697
Donna M MacCallumAberdeen Fungal Group, School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom.ORCID http://orcid.org/0000-0003-4833-0378
Lawrence C MyersDepartment of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America.
Dartmouth College · USTrinity College Dublin · IEUniversity of Aberdeen · GB

Funding

The Role of Yeast Mediator in Transcriptional RegulationR01GM062483 · NIGMS · DARTMOUTH COLLEGE · PI MYERS, LAWRENCE CHRISTOPHER · 2001 to 2012
$2.5M
Mediator regulation of transporters in fluconazole resistant C. albicans mutantsR21AI113390 · NIAID · DARTMOUTH COLLEGE · PI MYERS, LAWRENCE CHRISTOPHER · 2014 to 2015
$446k
NIAID NIH HHS R21 AI113390NIGMS NIH HHS R01 GM062483
6 · The paper itself

Abstract

Filamentous growth is a hallmark of C. albicans pathogenicity compared to less-virulent ascomycetes. A multitude of transcription factors regulate filamentous growth in response to specific environmental cues. Our work, however, suggests the evolutionary history of C. albicans that resulted in its filamentous growth plasticity may be tied to a change in the general transcription machinery rather than transcription factors and their specific targets. A key genomic difference between C. albicans and its less-virulent relatives, including its closest relative C. dubliniensis, is the unique expansion of the TLO (TeLOmere-associated) gene family in C. albicans. Individual Tlo proteins are fungal-specific subunits of Mediator, a large multi-subunit eukaryotic transcriptional co-activator complex. This amplification results in a large pool of 'free,' non-Mediator associated, Tlo protein present in C. albicans, but not in C. dubliniensis or other ascomycetes with attenuated virulence. We show that engineering a large 'free' pool of the C. dubliniensis Tlo2 (CdTlo2) protein in C. dubliniensis, through overexpression, results in a number of filamentation phenotypes typically associated only with C. albicans. The amplitude of these phenotypes is proportional to the amount of overexpressed CdTlo2 protein. Overexpression of other C. dubliniensis and C. albicans Tlo proteins do result in these phenotypes. Tlo proteins and their orthologs contain a Mediator interaction domain, and a potent transcriptional activation domain. Nuclear localization of the CdTlo2 activation domain, facilitated naturally by the Tlo Mediator binding domain or artificially through an appended nuclear localization signal, is sufficient for the CdTlo2 overexpression phenotypes. A C. albicans med3 null mutant causes multiple defects including the inability to localize Tlo proteins to the nucleus and reduced virulence in a murine systemic infection model. Our data supports a model in which the activation domain of 'free' Tlo protein competes with DNA bound transcription factors for targets that regulate key aspects of C. albicans cell physiology.

Indexed as

AnimalsCandida albicansCandidiasisFungiGene Expression Regulation, FungalGenomicsHumansHyphaeMicePhenotypeTelomereTelomere-Binding ProteinsTelomere-Binding Proteins

Identifiers

PMID27741243
PMCPMC5065183
OpenAlexW2531609592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.